CTOR
Citius Oncology, Inc.
0.851$
+0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | -186.5% | -238.0% | -190.7% | -277.3% | |
| – | – | – | – | – | – | – | – | – | 14.5% | 103.2% | 115.2% | – | |
| – | – | – | – | – | – | – | – | – | 100.3% | 211.5% | 238.4% | 187.8% | |
| – | – | – | – | – | – | – | – | – | -167.7% | 1,073.5% | 64.3% | 130.4% | |
| – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 133.9% | 28.1% | |
| – | – | – | – | – | – | – | – | – | -111.6% | -39.6% | -139.1% | -182.0% | |
| – | – | – | – | – | – | – | – | – | 383.5% | -3.0% | 1,280.1% | 696.4% | |
| – | – | – | – | – | – | – | – | – | 85.5% | -279.7% | 932.6% | 233.1% | |
| – | – | – | – | – | – | – | – | – | -186.5% | -238.0% | -190.7% | -277.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.